Galmed Pharmaceuticals Ltd. Ordinary Shares (NASDAQ: GLMD) last traded at $4.63, up 21.05% on the session. The quote above updates while this page is open; the figures below are drawn from Galmed Pharmaceuticals Ltd. Ordinary Shares’s own filings and are restated only when a new one is published.
Galmed Pharmaceuticals Ltd. Ordinary Shares trades on NASDAQ under the ticker GLMD. Its market capitalisation is $30.47 million.
Valuation measures for Galmed Pharmaceuticals Ltd. Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $30.47M |
|---|---|
| Enterprise value | $33.13M |
| P/E ratio | 1.94 |
| Price / book | 2.39 |
Trailing-twelve-month figures tagged in Galmed Pharmaceuticals Ltd. Ordinary Shares's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$11.34M |
| EPS (TTM) | $2.39 |
|---|
| Return on equity | -89.05% |
|---|
| Cash | $2.88M |
|---|
Range and volume for GLMD over the past 52 weeks.
| 52-week high | $4.88 |
|---|---|
| 52-week low | $3.12 |
| Volume | 301.2K |
| Average volume | 7.6K |
| Previous close | $3.83 |
Invest a chosen dollar amount in Galmed Pharmaceuticals Ltd. Ordinary Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell GLMD.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.